Skip to main navigation Skip to search Skip to main content

Mirikizumab as Induction and Maintenance Therapy for Ulcerative Colitis

LUCENT Study Group, Jakob Benedict Seidelin (Member of author group)

297 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Mirikizumab as Induction and Maintenance Therapy for Ulcerative Colitis'. Together they form a unique fingerprint.
Sort by

Pharmacology, Toxicology and Pharmaceutical Science

Immunology and Microbiology

Keyphrases